Skip to main content
Log in

Silver-nanoparticle exposure on immune system of mice depending on the route of administration

  • Published:
Nanotechnologies in Russia Aims and scope Submit manuscript

Abstract

In this study we have identified the influence of Argovit on the immune system of mice after inhalation or intragastric or subcutaneous administration. Argovit is a preparation of polyvinylpyrrolidone-coated (43.6 ± 10.7 nm) silver nanoparticles. We have found no toxic effect on the immune cells and organs, changes in T- and B-lymphocytes quantity in the spleen, or proinflammatory cytokine production after exposure to silver nanoparticles through inhalation or intragastrically. The subcutaneous administration of silver nanoparticles has changed the ratio of lymphocyte subpopulations, increased the quantity of IFN-γ-producing T-lymphocytes 3.6-fold compared with the control, and increased the content of IFN-γ in the serum of mice to 125 ± 9.2 pg/mL compared to the control (74.5 ± 6.4 pg/mL).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. E. J. Coligan, Short Protocols in Immunology: a Compendium of Methods from Current Protocols in Immunology, Ed. by E. J. Coligan, E. B. Bierer, H. D. Margulies, E. M. Shevach, and W. Stroder (John Wiley and Sons, Hoboken, NJ, 2005).

  2. W. H. De Jong, L. M. Van Der Ven, A. Sleijffers, M. V. D. Z. Park, E. H. J. M. Jansen, H. Van Loveren, and R. J. Vandebriel, “Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats,” Biomaterials 34(33), 8333–8343 (2013).

    Article  Google Scholar 

  3. A. E. Hawley, S. S. Davis, and L. Illum, “Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristics,” Adv. Drug Deliv. Rev. 17, 129–148 (1995).

    Article  Google Scholar 

  4. M. Higuchi, A. Fokin, T. N. Masters, F. Robicsek, and G. W. Schmid-Schonbein, “Transport of colloidal particles in lymphatics and vasculature after subcutaneous injection,” J. Appl. Physiol. 86, 1381–1387 (1999).

    Google Scholar 

  5. F. Ikomi, G. K. Hanna, and G. W. Schmid-Schonbein, “Size- and surface-dependent uptake of colloid particles into the lymphatic system,” Lymphology 32, 90–102 (1999).

    Google Scholar 

  6. S. H. E. Kaufmann, Methods in Microbiology, Vol. 32: Immunology of Infection, Ed. by S. H. E. Kaufmann and D. Kabelitz, 2nd ed. (Acad. Press, London, 2002).

  7. M. Korani, S. M. Rezayat, K. Gilani, BidgoliS. Arbabi, and S. Adeli, “Acute and subchronic dermal toxicity of nanosilver in guinea pig,” Int. J. Nanomed. 6, 855–862 (2011).

    Article  Google Scholar 

  8. K. Loeschner, N. Hadrup, K. Qvortrup, A. Larsen, X. Gao, U. Vogel, A. Mortensen, H. Rye Lam, and E. H. Larsen, “Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate,” Part. Fibre Toxicol. 8(18) (2011). doi:10.1186/1743-8977-8-18

    Google Scholar 

  9. T. Mosmann, “Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays,” J. Immunol. Methods 65(1–2), 55–63 (1983).

    Article  Google Scholar 

  10. “Nanosilver: safety, health and environmental effects and role in antimicrobial resistance,” in Proc. 4th Plenary of Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) (European Commission, Dec. 12, 2013).

  11. K. C. Nguyen, V. L. Seligy, A. Massarsky, T. W. Moon, P. Rippstein, J. Tan, and A. F. Tayabali, “Comparison of toxicity of uncoated and coated silver nanoparticles,” J. Phys.: Conf. Ser. 429, 012025 (2013).

    Google Scholar 

  12. E. J. Park, E. Baeb, J. Yib, Y. Kimc, K. Choid, S. H. Leed, J. Yoond, B. C. Leed, and K. Park, “Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles,” Environ. Toxicol. Pharmacol. 30, 162–168 (2010).

    Article  Google Scholar 

  13. R. Rustogi, J. Mill, J. F. Fraser, and R. M. Kimble, “The use of Acticoat TM in neonatal burns,” Burns 31, 878–882 (2005).

    Article  Google Scholar 

  14. L. V. Stebounova, A. Adamcakova, J. S. Kim, H. Park, O’Shaughnessy P.T., V. H. Grassian and P. S. Thorne, “Nanosilver indiced minimal lung toxicity or inflammation in a subacute murine inhalation model,” Part. Fibre Toxicol. 8(5) (2011). doi:10.1186/1743-8977-8-5

    Google Scholar 

  15. J. Tang, L. Xiong, S. Wang, J. Wang, L. Liu, J. Li, F. Yuan, and T. Xi, “Distribution, translocation and accumulation of silver nanoparticles in rats,” J. Nanosci. Nanotechnol. 9(8), 4924–4932 (2009).

    Article  Google Scholar 

  16. M. Van Der Zande, R. J. Vandebriel, E. Van Doren, E. Kramer, Z. Herrera Rivera, C. S. Serrano-Rojero, E. R. Gremmer, J. Mast, R. J. Peters, P. C. Hollman, P. J. Hendriksen, H. J. Marvin, A. A. Peijnenburg, and H. Bouwmeester, “Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure,” ACS Nano. 6 (8), 7427–7442 (2012).

    Article  Google Scholar 

  17. S. W. P. Wijnhoven, W. J. G. M. Peijnenburg, C. A. A. Herberts, W. I. Hagens, A. G. Oomen, E. H. W. Heugens, B. Roszek, J. Bisschops, I. Gosens, D. Van De Meent, S. Dekkers, W. H. De Jong, M. Van Zijverden, A. J. A. M. Sips, and R. Geertsma, “Nano-silver-a review of available data and knowledge gaps in human and environmental risk assessment,” Nanotoxicology 3(2), 109–138 (2009).

    Article  Google Scholar 

  18. S. C. Yah, S. G. Simate, and E. S. Iyuke, “Nanoparticles toxicity and their routes of exposures,” Pakistan J. Pharmaceut. Sci. 25(2), 477–491 (2012).

    Google Scholar 

  19. S. Zolnik Banu, A. Gonzalez-Fernandez, N. Sadrieh, and M. A. Dobrovolskai, “Minireview: nanoparticles and the immune system,” Endocrinology 151(2), 458–465 (2010).

    Article  Google Scholar 

  20. Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animals Resources, Commission on Life Sciences, National Research Council, National Acad. Press, Washington, 1996).

  21. A. A. Shumakova, V. V. Smirnova, O. N. Tananova, E. N. Trushina, L. V. Kravchenko, I. V. Aksenov, A. V. Selifanov, S. Kh. Soto, G. G. Kuznetsova, A. V. Bulakhov, I. V. Safenkova, I. V. Gmoshinskii, and S. A. Khotimchenko, “Toxicological-hygienic characteristics of silver nanoparticles injected into rat gastrointestinal tract,” Vopr. Pitaniya 80(6), 9–18 (2011).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to O. V. Kalmantaeva.

Additional information

Original Russian Text © O.V. Kalmantaeva, V.V. Firstova, V.D. Potapov, E.V. Zyrina, V.N. Gerasimov, E.A. Ganina, V.A. Burmistrov, A.V. Borisov, 2014, published in Rossiiskie Nanotekhnologii, 2014, Vol. 9, Nos. 9–10.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kalmantaeva, O.V., Firstova, V.V., Potapov, V.D. et al. Silver-nanoparticle exposure on immune system of mice depending on the route of administration. Nanotechnol Russia 9, 571–576 (2014). https://doi.org/10.1134/S1995078014050061

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1995078014050061

Keywords

Navigation